PacBio Announces AI Drug-Discovery Partnership with TychoBio
PacBio (PACB) has announced a partnership with TychoBio to advance AI-based drug discovery efforts. This news comes after an eight-session rally that saw PACB shares more than double in value.
PacBio (PACB) drew investor attention on Tuesday after the biotech company announced a partnership with TychoBio, extending its push into AI-based drug discovery. After an eight-session rally that more than doubled its value, PACB shares were down over 6% at the time of writing. PacBio To Generate Data From Mo…